P
ProHub
English 简体中文 繁體中文
BCG Easy Profitability

MedTech Co.

#Healthcare
ProHub Comment

This case combines financial analysis with market positioning to drive portfolio optimization decisions. The structure guides candidates from profitability calculations through market attractiveness assessment, requiring synthesis of quantitative and qualitative factors. The case emphasizes both financial rigor and strategic thinking about growth potential and competitive positioning.

Estimated Time 15 minutes
Difficulty Easy
Source Duke
50 / 100
Your client, MedTech Co, is a US-based, mid-sized medical technology manufacturer with five major product lines: diagnostics, surgical tools, monitoring, orthopedic devices, and laboratory equipment. The company has faced declining profitability in recent years. The CEO has asked for a recommendation on how to optimize their product portfolio.

Clarifying Information

  1. Objective: Focus on high-growth, high-margin product lines; potentially exit or restructure underperforming segments
  2. Model: Primary customers are hospitals and integrated health systems, with some sales to outpatient clinics and labs. Diagnostics and Monitoring lines include bundled hardware + software + service contracts (with higher recurring revenue). Surgical Tools & Lab Equipment lines are more transactional, with lower recurring revenue
  3. Timeline: Recommendation due in ~2 weeks, with staged rollouts over the next 18 months